Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

Market Cap	7.92B +3.6%
Revenue (ttm)	3.13B -30.0%
Net Income	281.38M -33.8%
EPS	0.49 -33.7%
Shares Out	566.16M
PE Ratio	28.51
Forward PE	18.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,904,500
Average Volume	5,132,381
Open	14.22
Previous Close	14.28
Day's Range	13.98 - 14.35
52-Week Range	11.95 - 20.20
Beta	0.61
RSI	42.40
Earnings Date	Apr 23, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1975
• Employees: 6,132
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600557

Financial Performance

In 2024, SHA:600557's revenue was 3.90 billion, a decrease of -19.86% compared to the previous year's 4.86 billion. Earnings were 391.86 million, a decrease of -15.58%.